These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 28586116)

  • 1. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial.
    Bajaj JS; Kassam Z; Fagan A; Gavis EA; Liu E; Cox IJ; Kheradman R; Heuman D; Wang J; Gurry T; Williams R; Sikaroodi M; Fuchs M; Alm E; John B; Thacker LR; Riva A; Smith M; Taylor-Robinson SD; Gillevet PM
    Hepatology; 2017 Dec; 66(6):1727-1738. PubMed ID: 28586116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial.
    Bajaj JS; Salzman NH; Acharya C; Sterling RK; White MB; Gavis EA; Fagan A; Hayward M; Holtz ML; Matherly S; Lee H; Osman M; Siddiqui MS; Fuchs M; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2019 Nov; 70(5):1690-1703. PubMed ID: 31038755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplant improves cognition in hepatic encephalopathy and its effect varies by donor and recipient.
    Bloom PP; Donlan J; Torres Soto M; Daidone M; Hohmann E; Chung RT
    Hepatol Commun; 2022 Aug; 6(8):2079-2089. PubMed ID: 35384391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial functional change is linked with clinical outcomes after capsular fecal transplant in cirrhosis.
    Bajaj JS; Salzman N; Acharya C; Takei H; Kakiyama G; Fagan A; White MB; Gavis EA; Holtz ML; Hayward M; Nittono H; Hylemon PB; Cox IJ; Williams R; Taylor-Robinson SD; Sterling RK; Matherly SC; Fuchs M; Lee H; Puri P; Stravitz RT; Sanyal AJ; Ajayi L; Le Guennec A; Atkinson RA; Siddiqui MS; Luketic V; Pandak WM; Sikaroodi M; Gillevet PM
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31751317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience with single fecal microbiota transplant for treatment of recurrent overt hepatic encephalopathy-A case series.
    Mehta R; Kabrawala M; Nandwani S; Kalra P; Patel C; Desai P; Parekh K
    Indian J Gastroenterol; 2018 Nov; 37(6):559-562. PubMed ID: 30474827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.
    Madsen M; Kimer N; Bendtsen F; Petersen AM
    Scand J Gastroenterol; 2021 May; 56(5):560-569. PubMed ID: 33840331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder.
    Bajaj JS; Gavis EA; Fagan A; Wade JB; Thacker LR; Fuchs M; Patel S; Davis B; Meador J; Puri P; Sikaroodi M; Gillevet PM
    Hepatology; 2021 May; 73(5):1688-1700. PubMed ID: 32750174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials.
    Bajaj JS; Shamsaddini A; Fagan A; Sterling RK; Gavis E; Khoruts A; Fuchs M; Lee H; Sikaroodi M; Gillevet PM
    Hepatol Commun; 2021 Feb; 5(2):258-271. PubMed ID: 33553973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant.
    Bajaj JS; Kakiyama G; Savidge T; Takei H; Kassam ZA; Fagan A; Gavis EA; Pandak WM; Nittono H; Hylemon PB; Boonma P; Haag A; Heuman DM; Fuchs M; John B; Sikaroodi M; Gillevet PM
    Hepatology; 2018 Oct; 68(4):1549-1558. PubMed ID: 29665102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes of Stool Transplant in Alcohol-associated Hepatitis-Analysis of Clinical Outcomes, Relapse, Gut Microbiota and Comparisons with Standard Care.
    Philips CA; Ahamed R; Rajesh S; Abduljaleel JKP; Augustine P
    J Clin Exp Hepatol; 2022; 12(4):1124-1132. PubMed ID: 35814513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individuals.
    Vujkovic-Cvijin I; Rutishauser RL; Pao M; Hunt PW; Lynch SV; McCune JM; Somsouk M
    Gut Microbes; 2017 Sep; 8(5):440-450. PubMed ID: 28541799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial.
    Sharma A; Roy A; Premkumar M; Verma N; Duseja A; Taneja S; Grover S; Chopra M; Dhiman RK
    Hepatol Int; 2022 Apr; 16(2):433-446. PubMed ID: 35349076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation in hepatic encephalopathy : a review of the current evidence and future perspectives.
    Afecto E; Ponte A; Fernandes S; Silva J; Gomes C; Correia J; Carvalho J
    Acta Gastroenterol Belg; 2021; 84(1):87-90. PubMed ID: 33639698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction.
    Wang WW; Zhang Y; Huang XB; You N; Zheng L; Li J
    World J Gastroenterol; 2017 Oct; 23(38):6983-6994. PubMed ID: 29097871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant.
    Liu R; Kang JD; Sartor RB; Sikaroodi M; Fagan A; Gavis EA; Zhou H; Hylemon PB; Herzog JW; Li X; Lippman RH; Gonzalez-Maeso J; Wade JB; Ghosh S; Gurley E; Gillevet PM; Bajaj JS
    Hepatology; 2020 Feb; 71(2):611-626. PubMed ID: 31220352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment.
    Hassouneh R; Bajaj JS
    J Clin Med; 2021 Jan; 10(2):. PubMed ID: 33477417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.